A Phase II Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients with Refractory Gastrointestinal Stromal Tumor

Conditions

Cancer | Other Digestive Organ

What is the purpose of this trial?

To determine the progression-free survival (PFS) of patients with refractory GIST treated with AUY922.


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Sarah Cannon Research Institute Oncology Research Consortium
Dates:
07/30/2013
Last Updated:
Study HIC#:
1301011364